QEMM Performance — SPDR MSCI Emerging Markets StrategicFactors ETF
Data updated: 2026-08-28
QEMM returned +19.96% year to date and +31.31% over one year to Jun 2026. Annualised returns are +18.14% over 3 years and +6.85% over 5 years. The fund trailed its Emerging Markets Equity category average: $100 invested three years ago grew to $165, against $179 for the category, and to $131 over one year, against $141. Volatility over the past three years was 14.62% a year. In the 12 months to Jun 2026 the fund took in a net $6.0M, and assets reached $55.06M.
QEMM Growth of $100
What $100 invested in SPDR MSCI Emerging Markets StrategicFactors ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | QEMM | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $131 | $141 |
| 3 years (Jul 2023 – Jun 2026) | $165 | $179 |
| 5 years (Jul 2021 – Jun 2026) | $139 | $144 |
| Since data start (Jul 2019 – Jun 2026) | $175 | $195 |
QEMM Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +19.96% |
| 1 year | +31.31% |
| 3 years (annualised) | +18.14% |
| 5 years (annualised) | +6.85% |
QEMM Annual Returns
Calendar-year total returns of SPDR MSCI Emerging Markets StrategicFactors ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +19.96% |
| 2025 | +21.23% |
| 2024 | +6.03% |
| 2023 | +11.64% |
| 2022 | −17.42% |
| 2021 | +6.04% |
| 2020 | +10.47% |
| 2019 (Jul–Dec) | +5.08% |
QEMM Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +6.8% | +4.9% | −9.9% | +13.2% | +7.9% | −2.7% | — | — | — | — | — | — |
| 2025 | +0.9% | −1.5% | +0.8% | +1.7% | +3.6% | +4.9% | +0.7% | +1.3% | +3.4% | +3.3% | −1.3% | +1.8% |
| 2024 | −3.2% | +4.4% | +0.1% | −0.1% | +1.2% | +2.8% | +1.2% | +1.6% | +5.2% | −4.5% | −2.4% | 0.0% |
| 2023 | +6.0% | −4.5% | +2.5% | +0.2% | −2.1% | +2.5% | +4.5% | −4.5% | −1.1% | −3.0% | +7.5% | +3.9% |
| 2022 | −1.9% | −1.4% | −1.1% | −5.2% | −0.2% | −6.9% | +0.5% | −0.7% | −8.9% | −1.7% | +11.7% | −1.9% |
| 2021 | +1.5% | +1.0% | +1.2% | +1.7% | +2.5% | 0.0% | −4.3% | +3.3% | −2.2% | −0.1% | −2.2% | +3.7% |
| 2020 | −5.3% | −5.3% | −14.0% | +8.9% | −0.2% | +4.9% | +7.0% | +1.2% | −1.5% | +0.8% | +9.2% | +7.0% |
| 2019 | — | — | — | — | — | — | −0.8% | −3.9% | +2.2% | +3.5% | −1.5% | +5.8% |
QEMM Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 14.62%
- 3-year Sharpe ratio: 0.93 (vs 4.5% risk-free rate)
- Best month: +13.22% (Apr 2026)
- Worst month: −9.92% (Mar 2026)
QEMM Fund Flows
Monthly money in and out of SPDR MSCI Emerging Markets StrategicFactors ETF, from SEC Form N-PORT.
- 12-month net flow: $6.0M
- 12-month gross sales (incl. reinvestments): $6.0M
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $4.1M | $0 | $4.1M |
| May 2026 | $2.0M | $0 | $2.0M |
| Apr 2026 | $0 | $0 | $0 |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $0 | $0 | $0 |
| Jan 2026 | $0 | $0 | $0 |
| Dec 2025 | $0 | $0 | $0 |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $0 | $0 | $0 |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $0 | $0 | $0 |
| Jul 2025 | $0 | $0 | $0 |
QEMM Assets Under Management
Net assets of SPDR MSCI Emerging Markets StrategicFactors ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $55.06M |
| 2026-03-31 | $41.90M |
| 2025-12-31 | $41.52M |
| 2025-09-30 | $41.51M |
| 2025-06-30 | $39.36M |
| 2025-03-31 | $37.52M |
| 2024-12-31 | $43.18M |
| 2024-09-30 | $49.32M |
| 2024-06-30 | $45.57M |
| 2024-03-31 | $44.76M |
| 2023-12-31 | $48.53M |
| 2023-09-30 | $46.06M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.